These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 8439262)

  • 1. Successful treatment of immobilization hypercalcemia using calcitonin and etidronate.
    Meythaler JM; Tuel SM; Cross LL
    Arch Phys Med Rehabil; 1993 Mar; 74(3):316-9. PubMed ID: 8439262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immobilization hypercalcemia associated with Landry-Guillain-Barré syndrome. Successful therapy with combined calcitonin and etidronate.
    Meythaler JM; Korkor AB; Nanda T; Kumar NA; Fallon M
    Arch Intern Med; 1986 Aug; 146(8):1567-71. PubMed ID: 3089187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcitonin therapy in prolonged immobilization hypercalcemia.
    Carey DE; Raisz LG
    Arch Phys Med Rehabil; 1985 Sep; 66(9):640-4. PubMed ID: 4038033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immobilization hypercalcemia in acute spinal cord injury treated with etidronate.
    Merli GJ; McElwain GE; Adler AG; Martin JH; Roberts JD; Schnall B; Ditunno JF
    Arch Intern Med; 1984 Jun; 144(6):1286-8. PubMed ID: 6428341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hypercalcemia due to immobilization in critically ill children: calcitnonin treatment].
    Urán Moreno M; Alonso Riofrío R; Moliner Robredo C; Pons Morales S; López-Herce Cid J
    An Esp Pediatr; 2001 Jun; 54(6):555-8. PubMed ID: 11412402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of clodronate on immobilization bone loss.
    Minaire P; Depassio J; Berard E; Meunier PJ; Edouard C; Pilonchery G; Goedert G
    Bone; 1987; 8 Suppl 1():S63-8. PubMed ID: 2961357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of a 24-hour infusion of etidronate disodium in the treatment of hypercalcemia of malignant disease. A dose-ranging pilot study.
    Flores JF; Singer FR; Rude RK
    Miner Electrolyte Metab; 1991; 17(6):390-5. PubMed ID: 1823390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous etidronate in the management of malignant hypercalcemia.
    Ryzen E; Martodam RR; Troxell M; Benson A; Paterson A; Shepard K; Hicks R
    Arch Intern Med; 1985 Mar; 145(3):449-52. PubMed ID: 3919667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A retrospective evaluation of the medical treatment of malignancy-associated hypercalcemia.
    Kimura S; Sato Y; Matsubara H; Adachi I; Yamaguchi K; Suzuki M; Suemasu K; Abe K
    Jpn J Cancer Res; 1986 Jan; 77(1):85-91. PubMed ID: 2937761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immobilization hypercalcemia in spinal cord injury.
    Maynard FM; Imai K
    Arch Phys Med Rehabil; 1977 Jan; 58(1):16-24. PubMed ID: 831659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of calcitonin and pamidronate for emergency treatment of malignant hypercalcemia.
    Sekine M; Takami H
    Oncol Rep; 1998; 5(1):197-9. PubMed ID: 9458321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immobilization hypercalcemia following spinal cord injury.
    Maynard FM
    Arch Phys Med Rehabil; 1986 Jan; 67(1):41-4. PubMed ID: 2935120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a 24-hour infusion of etidronate disodium for the treatment of hypercalcemia of malignancy.
    Flores JF; Rude RK; Chapman RA; Belani CP; Chang AY; Pritchard JD; Hoff JV
    Cancer; 1994 May; 73(10):2527-34. PubMed ID: 8174049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of oral administration of etidronate disodium in maintaining normal serum calcium levels in previously hypercalcemic cancer patients.
    Ringenberg QS; Ritch PS
    Clin Ther; 1987; 9(3):318-25. PubMed ID: 3111705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of resistant hypercalcemia of malignancy with a proposed treatment algorithm.
    McMahan J; Linneman T
    Ann Pharmacother; 2009 Sep; 43(9):1532-8. PubMed ID: 19622757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe immobilization hypercalcemia, renal insufficiency, and calcification.
    Conley SB; Shackelford GD; Robson AM
    Pediatrics; 1979 Jan; 63(1):142-5. PubMed ID: 440790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of severe hypercalcemia.
    Davis KD; Attie MF
    Crit Care Clin; 1991 Jan; 7(1):175-90. PubMed ID: 2007213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Synthetic salmon calcitonin as an antihypercalcemic agent for hypercalcemia in malignancy].
    Adachi I; Kimura S; Yamaguchi K; Suzuki M; Abe K
    Gan To Kagaku Ryoho; 1986 Aug; 13(8):2637-44. PubMed ID: 3740862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hypercalcemia in breast cancer].
    Okada Y; Ogawa M; Horikoshi N; Inagaki J; Inoue K; Ikeda K; Usui N; Nakada H; Adachi K; Mukaiyama T
    Gan To Kagaku Ryoho; 1984 Jul; 11(7):1468-74. PubMed ID: 6742868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.